title: Everolimus-Eluting Stent versus Sirolimus-Eluting Stent for prognostic significance.
authors.affiliation: Department of Cardiology, Special Izmir Avrupa Medicine Center, Karabaglar, Izmir, Turkey. Electronic address: mhmtybgl@gmail.com.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Eyuboglu
authors.affiliation: Department of Cardiology, Sifa University Hospital Buca, Izmir, Turkey.
authors.forename: Omer
authors.initials: O
authors.lastname: Senarslan
authors.affiliation: Department of Cardiology, Gördes State Hospital, Gördes, Manisa, Turkey.
authors.forename: Fatih
authors.initials: F
authors.lastname: Aytemiz
authors.affiliation: Department of Cardiology, Usak State Hospital, Usak, Turkey.
authors.forename: Ilhan
authors.initials: I
authors.lastname: Koyuncu
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000188:drug therapy; D023903:Coronary Restenosis / Q000188:drug therapy; D054855:Drug-Eluting Stents; D000068338:Everolimus; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy; D020123:Sirolimus / Q000627:therapeutic use*; D015607:Stents; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus
keywords: Drug-eluting stent; New generation; Prognosis